| None |
21+ years old |
View
|
| None |
Address |
View
|
| None |
Adult |
View
|
| None |
Amputation |
View
|
| None |
Area |
View
|
| None |
Diabetes Mellitus, Non-Insulin-Dependent |
View
|
| None |
Diabetes Mellitus, Noninsulin Dependent |
View
|
| None |
Diabetes Mellitus, Slow-Onset |
View
|
| None |
Diabetes Mellitus, Stable |
View
|
| None |
Diabetes Mellitus, Type 2 |
View
|
| None |
Diabetes Mellitus, Type II |
View
|
| None |
Disease |
View
|
| None |
Disease remission |
View
|
| None |
Disorder |
View
|
| None |
Drugs |
View
|
| None |
Dysfunction |
View
|
| None |
Effectiveness |
View
|
| None |
Epidemic |
View
|
| None |
Functional disorder |
View
|
| None |
Future |
View
|
| None |
Gastric Bypass |
View
|
| None |
Glucose |
View
|
| None |
Health |
View
|
| None |
Healthcare |
View
|
| None |
Hepatic Disorder |
View
|
| None |
Human, Adult |
View
|
| None |
Hypertension |
View
|
| None |
INFLM |
View
|
| None |
Incidence |
View
|
| None |
Inflammation |
View
|
| None |
Insulin Cell |
View
|
| None |
Insulin Resistance |
View
|
| None |
Insulin Secreting Cell |
View
|
| None |
Intestinal |
View
|
| None |
Intestines |
View
|
| None |
Intravenous Glucose Tolerance |
View
|
| None |
Intravenous Glucose Tolerance Test |
View
|
| None |
Kidney Failure |
View
|
| None |
Kidney Insufficiency |
View
|
| None |
Learning |
View
|
| None |
Life Style |
View
|
| None |
Life Style Modification |
View
|
| None |
Lifestyle |
View
|
| None |
Link |
View
|
| None |
Liver diseases |
View
|
| None |
Longitudinal Studies |
View
|
| None |
MODY |
View
|
| None |
Malignant Neoplasms |
View
|
| None |
Malignant Tumor |
View
|
| None |
Maturity-Onset Diabetes Mellitus |
View
|
| None |
Measures |
View
|
| None |
Medical |
View
|
| None |
Medication |
View
|
| None |
Metabolic |
View
|
| None |
Methods |
View
|
| None |
Modification |
View
|
| None |
Morbid Obesity |
View
|
| None |
Morbidity |
View
|
| None |
Morbidity - disease rate |
View
|
| None |
Mortality |
View
|
| None |
behavioral intervention |
View
|
| None |
blood glucose regulation |
View
|
| None |
body weight loss |
View
|
| None |
bowel |
View
|
| None |
cardiac infarct |
View
|
| None |
cardiovascular disorder |
View
|
| None |
designing |
View
|
| None |
diabetes |
View
|
| None |
diabetic patient |
View
|
| None |
disease/disorder |
View
|
| None |
drug/agent |
View
|
| None |
effective therapy |
View
|
| None |
effectiveness research |
View
|
| None |
fitness |
View
|
| None |
gastric banding |
View
|
| None |
gastric bypass surgery |
View
|
| None |
glucose control |
View
|
| None |
glucose homeostasis |
View
|
| None |
glucose metabolism |
View
|
| None |
glucose regulation |
View
|
| None |
heart attack |
View
|
| None |
heart infarct |
View
|
| None |
heart infarction |
View
|
| None |
hepatopathy |
View
|
| None |
hyperpiesia |
View
|
| None |
hyperpiesis |
View
|
| None |
hypertensive disease |
View
|
| None |
implantable gastric stimulation banding |
View
|
| None |
insulin resistant |
View
|
| None |
interest |
View
|
| None |
ketosis resistant diabetes |
View
|
| None |
life style intervention |
View
|
| None |
lifestyle intervention |
View
|
| None |
liver disorder |
View
|
| None |
long-term study |
View
|
| None |
malignancy |
View
|
| None |
maturity onset diabetes |
View
|
| None |
moderate obesity |
View
|
| None |
neoplasm/cancer |
View
|
| None |
non-alcohol fatty liver |
View
|
| None |
non-alcohol induced steatohepatitis |
View
|
| None |
non-alcoholic fatty liver |
View
|
| None |
non-alcoholic steato-hepatitis |
View
|
| None |
nonalcohol fatty liver |
View
|
| None |
nonalcoholic fatty liver |
View
|
| None |
nonalcoholic steato-hepatitis |
View
|
| None |
nonalcoholic steatohepatitis |
View
|
| None |
obese |
View
|
| None |
obese people |
View
|
| None |
obese person |
View
|
| None |
obese population |
View
|
| None |
obesity surgery |
View
|
| None |
obesity, extreme |
View
|
| None |
pathophysiology |
View
|
| None |
pilot study |
View
|
| None |
programs |
View
|
| None |
psychosocial |
View
|
| None |
psychosocial variables |
View
|
| None |
public health medicine (field) |
View
|
| None |
public health relevance |
View
|
| None |
randomisation |
View
|
| None |
randomization |
View
|
| None |
randomized controlled study |
View
|
| None |
randomized trial |
View
|
| None |
randomly assigned |
View
|
| None |
respiratory |
View
|
| None |
response |
View
|
| None |
stomach bypass |
View
|
| None |
stomach stapling |
View
|
| None |
surgery |
View
|
| None |
trial comparing |
View
|
| None |
vascular |
View
|
| None |
weight loss intervention |
View
|
| None |
weight loss surgery |
View
|
| None |
wt-loss |
View
|
| None |
cardiovascular risk |
View
|
| None |
cardiovascular risk factor |
View
|
| None |
clinical practice |
View
|
| None |
comparative effectiveness |
View
|
| None |
coronary attack |
View
|
| None |
coronary infarct |
View
|
| None |
coronary infarction |
View
|
| None |
corpulence |
View
|
| None |
corpulency |
View
|
| None |
corpulentia |
View
|
| None |
design |
View
|
| None |
Arm |
View
|
| None |
Atheroscleroses |
View
|
| None |
Atherosclerosis |
View
|
| None |
Atherosclerotic |
View
|
| None |
Cardiovascular Disease |
View
|
| None |
Bariatrics |
View
|
| None |
Behavior Conditioning Therapy |
View
|
| None |
Behavior Modification |
View
|
| None |
Behavior Therapy |
View
|
| None |
Behavior Treatment |
View
|
| None |
Behavior or Life Style Modifications |
View
|
| None |
Behavioral |
View
|
| None |
Behavioral Conditioning Therapy |
View
|
| None |
Behavioral Modification |
View
|
| None |
Behavioral Therapy |
View
|
| None |
Behavioral Treatment |
View
|
| None |
Beta Cell |
View
|
| None |
Blindness |
View
|
| None |
Blood Pressure, High |
View
|
| None |
Blood Vessels |
View
|
| None |
Body Composition |
View
|
| None |
Body Weight decreased |
View
|
| None |
Cancers |
View
|
| None |
Cardiac infarction |
View
|
| None |
Cardiovascular Diseases |
View
|
| None |
Care, Health |
View
|
| None |
Cause of Death |
View
|
| None |
Cell Function |
View
|
| None |
Cell Process |
View
|
| None |
Cell physiology |
View
|
| None |
Cellular Function |
View
|
| None |
Cellular Physiology |
View
|
| None |
Cellular Process |
View
|
| None |
Cessation of life |
View
|
| None |
Clinical |
View
|
| None |
Clinical Trials Design |
View
|
| None |
Communities |
View
|
| None |
Conditioning Therapy |
View
|
| None |
Controlled Clinical Trials, Randomized |
View
|
| None |
Controlled Study |
View
|
| None |
Country |
View
|
| None |
D-Glucose |
View
|
| None |
Death |
View
|
| None |
Decision Making |
View
|
| None |
Dextrose |
View
|
| None |
Diabetes Mellitus |
View
|
| None |
Diabetes Mellitus, Adult-Onset |
View
|
| None |
Diabetes Mellitus, Ketosis-Resistant |
View
|
| None |
Mortality Vital Statistics |
View
|
| None |
Myocardial Infarct |
View
|
| None |
Myocardial Infarction |
View
|
| None |
NAFLD |
View
|
| None |
NASH |
View
|
| None |
NIDDM |
View
|
| None |
Non-Insulin Dependent Diabetes |
View
|
| None |
Non-Insulin-Dependent Diabetes Mellitus |
View
|
| None |
Non-alcoholic steatohepatitis |
View
|
| None |
Obesity |
View
|
| None |
Obesity, Morbid |
View
|
| None |
Operation |
View
|
| None |
Operative Procedures |
View
|
| None |
Operative Surgical Procedures |
View
|
| None |
Outcome |
View
|
| None |
Outcome Measure |
View
|
| None |
PROV |
View
|
| None |
Participant |
View
|
| None |
Patients |
View
|
| None |
Pharmaceutic Preparations |
View
|
| None |
Pharmaceutical Preparations |
View
|
| None |
Physical activity |
View
|
| None |
Physiopathology |
View
|
| None |
Pilot Projects |
View
|
| None |
Population |
View
|
| None |
Procedures |
View
|
| None |
Programs (PT) |
View
|
| None |
Programs [Publication Type] |
View
|
| None |
Provider |
View
|
| None |
Psychosocial Factor |
View
|
| None |
Public Health |
View
|
| None |
RMSN |
View
|
| None |
Randomized |
View
|
| None |
Randomized Controlled Clinical Trials |
View
|
| None |
Randomized Controlled Trials |
View
|
| None |
Remission |
View
|
| None |
Renal Failure |
View
|
| None |
Renal Insufficiency |
View
|
| None |
Reporting |
View
|
| None |
Resolution |
View
|
| None |
Science |
View
|
| None |
Severe obesity |
View
|
| None |
Structure |
View
|
| None |
Subcellular Process |
View
|
| None |
Surgical |
View
|
| None |
Surgical Interventions |
View
|
| None |
Surgical Procedure |
View
|
| None |
T2D |
View
|
| None |
T2DM |
View
|
| None |
Testing |
View
|
| None |
Type 2 diabetes |
View
|
| None |
Type II diabetes |
View
|
| None |
United States |
View
|
| None |
Upper arm |
View
|
| None |
Vascular Hypertensive Disease |
View
|
| None |
Vascular Hypertensive Disorder |
View
|
| None |
Weight |
View
|
| None |
Weight Loss |
View
|
| None |
Weight Reduction |
View
|
| None |
Work |
View
|
| None |
adiposity |
View
|
| None |
adult human (21+) |
View
|
| None |
adult onset diabetes |
View
|
| None |
atheromatosis |
View
|
| None |
atherosclerotic vascular disease |
View
|
| None |
bariatric surgery |
View
|
| None |
behavior intervention |
View
|
| None |
Diet |
View
|